Thelansis

 Spinocerebellar ataxias (SCAs) are an extensive and heterogeneous group of autosomal dominant degenerative diseases characterized by progressive degeneration of the cerebellum and its afferent and efferent connections. The basal ganglia, brainstem nuclei, pyramidal tracts, posterior column, anterior horn, peripheral nerve, and other structures of the nervous system are typically also affected. SCAs are clinically characterized by the presence of cerebellar gait and limb ataxia (with dysmetria, dysdiado chokinesia, intention tremor, dysarthria, and nystagmus), which may be accompanied by extracerebellar signs such as ophthalmoplegia, pyramidal signs, movement disorders (including parkinsonism, dystonia, myoclonia, and chorea), dementia, epilepsy, visual disorders (including pigmentary retinopathy), lower motor neuron disease and peripheral neuropathy. ·        Spinocerebellar Ataxias (SCAs) accounts for 3% to 5% of the ataxic diagnosed population, wi...

 Spinocerebellar ataxias (SCAs) are an extensive and heterogeneous group of autosomal dominant degenerative diseases characterized by progressive degeneration of the cerebellum and its afferent and efferent connections. The basal ganglia, brainstem nuclei, pyramidal tracts, posterior column, anterior horn, peripheral nerve, and other structures of the nervous system are typically also affected. SCAs are clinically characterized by the presence of cerebellar gait and limb ataxia (with dysmetria, dysdiado chokinesia, intention tremor, dysarthria, and nystagmus), which may be accompanied by extracerebellar signs such as ophthalmoplegia, pyramidal signs, movement disorders (including parkinsonism, dystonia, myoclonia, and chorea), dementia, epilepsy, visual disorders (including pigmentary retinopathy), lower motor neuron disease and peripheral neuropathy. ·        Spinocerebellar Ataxias (SCAs) accounts for 3% to 5% of the ataxic diagnosed population, wi...